16:14 EDT PDS Biotechnology (PDSB) files $200M mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDSB:
- PDS Biotechnology Reports Promising Phase 2 Trial Results
- PDS Biotechnology Announces Promising Phase 2 Trial Results
- PDS Biotechnology announces data from its VERSATILE-002 Phase 2 trial
- PDS Biotechnology Reports Q2 2025 Financial Results
- PDS Biotechnology’s Promising Pipeline and Strong Financial Position Justify Buy Rating